Dr Reddy’s acquires Mayne Pharma’s USA prescription portfolio for $105 Mn

Under the terms of the agreement, Dr Reddy’s will acquire the portfolio for an upfront payment of approximately USD 90 million in cash, contingent payments of up to USD 15 million, consideration towards inventory and credits for certain accrued channel liabilities to be determined on the closing date, it said.